SCI Abstract

search
Wrapping up the evidence: bandaging in breast cancer-related lymphedema—a systematic review and meta-analysis
Wrapping up the evidence: bandaging in breast cancer-related lymphedema—a systematic review and meta-analysis
The standard approach for breast cancer-related lymphedema (BCRL) is Complex Decongestive Therapy. This therapy involves v...
Digitally quantified area of residual tumor after neoadjuvant chemotherapy in HER2-positive breast cancer
Digitally quantified area of residual tumor after neoadjuvant chemotherapy in HER2-positive breast cancer
The area of residual tumor (ART) is a quantitative method for assessing tumors after neoadjuvant chemotherapy (NAC). This ...
Constructing shared genetic architecture between bioavailable testosterone and luminal A breast cancer in female
Constructing shared genetic architecture between bioavailable testosterone and luminal A breast cancer in female
Observational studies have showed a strong association between bioavailable testosterone (BT) and breast cancer. However, ...
Relationship between psychological resilience and cognitive function on breast cancer chemotherapy patients: a person-centered method
Relationship between psychological resilience and cognitive function on breast cancer chemotherapy patients: a person-centered method
Previous studies have indicated a connection between resilience and cognitive function, but critical gaps persist regardin...
Annual report of National Clinical Database-Breast Cancer Registry in 2021: characteristics categorized by body mass index and menopause status
Annual report of National Clinical Database-Breast Cancer Registry in 2021: characteristics categorized by body mass index and menopause status
The Japanese Breast Cancer Society initiated the breast cancer registry in 1975 and migrated the registry to the National ...
Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breast
Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breast
High tumor mutational burden (TMB-H) is an established biomarker for a favorable response to immune checkpoint inhibitors....
ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer
ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer
ATPase copper transporting beta (ATP7B) functions as a copper-transporting ATPase that ejects copper from cells. Although ...
Polymorphous adenocarcinoma-like tumor of the breast: the first case report from Japan
Polymorphous adenocarcinoma-like tumor of the breast: the first case report from Japan
Polymorphous adenocarcinoma-like (PmA-like) tumor of the breast is a rare salivary gland-like neoplasm, with few cases rep...
Influence of age on patient decision regret following breast reconstruction: a multicenter collaborative study in Japan
Influence of age on patient decision regret following breast reconstruction: a multicenter collaborative study in Japan
In recent years, the age range of patients undergoing breast reconstruction has expanded. Establishment of the influence o...
Why combine and why neoadjuvant? Tumor immunological perspectives on chemoimmunotherapy in triple-negative breast cancer
Why combine and why neoadjuvant? Tumor immunological perspectives on chemoimmunotherapy in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by limited targeted therapies and high recurre...
A nomogram to predict the benefit of postmastectomy radiotherapy in breast cancer with nodal micrometastases
A nomogram to predict the benefit of postmastectomy radiotherapy in breast cancer with nodal micrometastases
The role of postmastectomy radiotherapy (PMRT) in breast cancer (BC) with nodal micrometastases (N1mic) remains unclear. T...
Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors
Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors
There have been concerns about the use of tumor necrosis factor inhibitors (TNFi) for autoimmune disease in patients with ...
Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA
Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA
Breast cancer (BC) is the most common cancer in women and accounts for approximately 15% of all cancer deaths among women ...
Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer
Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer
Chemotherapy is crucial for hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative breast can...
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort
The study focuses on enhancing breast cancer (BC) prognosis through early detection, aiming to establish a non-invasive, c...
Applying whole-genome and whole-exome sequencing in breast cancer: a review of the landscape
Applying whole-genome and whole-exome sequencing in breast cancer: a review of the landscape
Whole-genome sequencing (WGS) and whole-exome sequencing (WES) are crucial within the context of breast cancer (BC) resear...
Desire for pregnancy and fertility preservation in young patients with breast cancer
Desire for pregnancy and fertility preservation in young patients with breast cancer
Data on the desire for pregnancy and the status of fertility preservation (FP) in patients with breast cancer remain uncle...
PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer
PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a highly heterogeneous tumor lacking estrogen receptor (ER), progesterone receptor...